US Edition
News from contagionlive.com
We’ve assigned a media bias rating of unknown to contagionlive.com. You can read more about our methodology here.
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top contagionlive.com News
Robert F. Kennedy Jr. · United StatesHealth and Human Services Secretary Robert F. Kennedy Jr. on Monday said he is “retiring” all 17 members of a crucial government panel of vaccine advisors. “A clean sweep is needed to re-establish public confidence in vaccine science,” Kennedy said in an opinion piece in the Wall Street Journal on Monday.
See the Story
RFK Jr. removes all members of CDC panel advising U.S. on vaccines
44% Center coverage: 69 sources
Hepatitis C · United StatesEditor's Note: This headline and story have been updated to clarify that the FDA approval was for an expanded indication to treat acute HCV. The U.S. Food and Drug Administration (FDA) approved a label expansion for AbbVie Inc's (NYSE:ABBV) Mavyret (glecaprevir/pibrentasvir) to include treatment of acute hepatitis C virus (HCV) infection in patients without cirrhosis or with compensated cirrhosis. Glecaprevir, one of the two DAAs in Mavyret, was…See the Story
FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED) - Enanta Pharma (NASDAQ:ENTA), AbbVie (NYSE:ABBV)
73% Center coverage: 15 sources
How You Can Help Protect Your Baby Against Rotavirus
67% Center coverage: 3 sources
